ATS/ERS stage | |||
---|---|---|---|
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 41.2 | 59.8 | 68.3 |
Ischemic heart disease (%) | 13.0 | 13.2 | 19.9 |
Cerebro-vascular disease (%) | 4.5 | 3.7 | 6.4 |
Diabetes (%) | 11.7 | 9.6 | 12.1 |
Cancer (%) | 4.0 | 3.7 | 4.3 |
6MWD % predicted (mean [SD]) | 81.0 (26.3) | 78.2 (24.0) | 68.6 (24.2) |
GDS score (mean [SD]) | 3.5 (3.3) | 2.8 (3.1)1 | 3.7 (3.3) |
MMSE score (mean [SD]) | 27.7 (3.0) | 27.4 (2.8) | 26.7 (4.2) |
Barthel Index (mean [SD]) | 95.0 (7.9) | 95.8 (5.0)1 | 92.8 (7.6) |
BTS stage | |||
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 43.3 | 63.0 | 76.5 |
Ischemic heart disease (%) | 12.4 | 22.0 | 14.7 |
Cerebro-vascular disease (%) | 4.4 | 5.3 | 11.8 |
Diabetes (%) | 10.9 | 12.1 | 13.2 |
Cancer (%) | 3.8 | 6.1 | 1.5 |
6MWD % predicted (mean [SD]) | 80.6 (26.2) | 76.3 (21.7) | 62.8 (25.3) |
GDS score (mean [SD]) | 3.5 (3.3) | 3.2 (3.2) | 3.5 (3.0) |
MMSE score (mean [SD]) | 27.7 (2.9) | 26.9 (3.9)1 | 26.8 (4.2) |
Barthel Index (mean [SD]) | 96 (7.7) | 95.2 (4.8) | 91.5 (8.5) |
GOLD stage | |||
No Obstruction | Mild obstruction | Moderate/Severe obstruction | |
Males (%) | 40.4 | 59.5 | 67.5 |
Ischemic heart disease (%) | 13.5 | 6.4 | 19.5 |
Cerebro-vascular disease (%) | 4.5 | 3.8 | 5.5 |
Diabetes (%) | 11.7 | 6.4 | 12.5 |
Cancer (%) | 4.0 | 2.6 | 4.5 |
6MWD % predicted (mean [SD]) | 81.3 (26.2) | 77.5 (26.0) | 71.1 (23.9) |
GDS score (mean [SD]) | 3.6 (3.3) | 2.9 (3.3)1 | 3.3 (3.2) |
MMSE score (mean [SD]) | 27.7 (3.0) | 27.7 (2.6) | 26.8 (4.0) |
Barthel Index (mean [SD]) | 94.9 (8.0) | 95.8 (5.7)1 | 94.0 (6.5) |